Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) EBT Margin (2016 - 2025)

Apyx Medical (APYX) has disclosed EBT Margin for 15 consecutive years, with 5.98% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 15499.0% year-over-year to 5.98%, compared with a TTM value of 20.5% through Dec 2025, down 2561.0%, and an annual FY2025 reading of 20.5%, down 2561.0% over the prior year.
  • EBT Margin was 5.98% for Q4 2025 at Apyx Medical, up from 14.58% in the prior quarter.
  • Across five years, EBT Margin topped out at 149.01% in Q4 2024 and bottomed at 73.57% in Q1 2024.
  • Average EBT Margin over 5 years is 31.19%, with a median of 42.71% recorded in 2023.
  • The sharpest move saw EBT Margin soared 21405bps in 2024, then crashed -15499bps in 2025.
  • Year by year, EBT Margin stood at 11.15% in 2021, then crashed by -321bps to 46.9% in 2022, then crashed by -39bps to 65.05% in 2023, then soared by 329bps to 149.01% in 2024, then plummeted by -104bps to 5.98% in 2025.
  • Business Quant data shows EBT Margin for APYX at 5.98% in Q4 2025, 14.58% in Q3 2025, and 32.44% in Q2 2025.